Commitment to Integrity, Transparency and Diversity
For more than 230 years, the Takeda brand has embodied the values of fairness, honesty, and most importantly, integrity. Known as “Takeda-ism,” these core values serve as guiding principles in our pursuit to promote better health and brighter futures for our patients through innovative medicines.
Today, Takeda continues our tradition of integrity by prioritizing clinical research transparency and making clinical research information and results available to the public.
“Greater transparency and responsible data sharing during development of new medicines and throughout their life cycles are core topics for the pharmaceutical industry. At Takeda, we recognize that responsible sharing of clinical trial data with patients, healthcare providers, researchers, and the public is critical to delivering innovative medicines. Increased transparency improves public trust in our products and treatments and helps all our stakeholders make better healthcare decisions.”Jeremy G Chadwick, Ph.D., Head of Global Development Office, Takeda R&D
Takeda is committed to compliance with clinical trial transparency laws and regulations as well as an objective, unbiased clinical trial results reporting, regardless of outcome. This includes a broader sharing of clinical trial data in ways that safeguard patient privacy, respect regulatory processes and oversight, and maintain incentives to invest in biomedical research.
Our policies meet or exceed the pharmaceutical industry’s guidelines and best practices relating to clinical trial registration and results disclosure, including guidelines issued by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); the European Federation of Pharmaceutical Industries and Associations (EFPIA); the Japan Pharmaceutical Manufacturers Association (JPMA); and the Pharmaceutical Research and Manufacturers of America (PhRMA).
Takeda adheres to and seeks to exceed requirements laid out by the Principles for Responsible Clinical Trial Data Sharing, which were issued by the EFPIA and PhRMA in July 2013. Takeda will do this by:
To further promote transparency, Takeda developed a Find a Trial search tool to identify Takeda sponsored interventional and non-interventional clinical trials and provide easy searchability for information on a particular condition/disease; available trials near a defined location; trial entry criteria and design elements, as well as a summary of study results, all written in plain language.
Diversity in clinical trial participation leads to better research, treatment and health outcomes for individuals from a diverse range of backgrounds according, but not limited to age, gender, race and ethnicity. Because some groups have been underrepresented in clinical research in the past, there is an urgent need to ensure appropriate representation in clinical trials and to gain information about treatment outcomes in diverse populations. This is particularly important for clinical trials studying diseases that disproportionately affect specific ethnic minorities.
Takeda is therefore focused on enhancing the diversity of clinical trial populations and promoting participants’ enrollment practices to provide clinical trial results that better reflect the populations most likely to use medical products once they are approved. Takeda established concrete policies and practices to address diversity in clinical trials, as outlined in the PhRMA Principles on the Conduct of Clinical Trials.
At Takeda, we believe that in order to achieve health equity, everyone must have a fair and just opportunity to attain their full health potential, regardless of social position or other social determinants. We are working to achieve greater health equity for all patients by addressing health disparities and inequities that disproportionately impact underserved communities, including access to clinical trials. While the biopharmaceutical industry and our partners continue to make strides, there is a lot more work to be done to ensure clinical trials are diverse, inclusive and better reflect the patients we serve. At Takeda, we are committed to creating a more diverse, equitable and inclusive culture not only within our own walls and our communities but also across our clinical trials. True to our values – perseverance, integrity, honesty and fairness – for us, enhancing diversity in clinical trials is simply the right thing to do.
Find more details about Takeda’s Commitment to Diversity, Equity and Inclusion.